Search results
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
More people sent to hospital as mushroom-infused 'microdosing' chocolate faces ongoing FDA probe
Fox News via Yahoo News· 17 hours agoThe FDA recently announced that 10 consumers who ate Diamond Shruumz "microdosing" chocolate and...
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
FierceBiotech· 4 hours agoThe FDA has slammed the brakes on MediLink Therapeutics’ trial of a BioNTech-partnered antibody-drug...
Abortion pill ruling offers measure of relief for FDA, biotech
BioPharma Dive via Yahoo Finance· 6 hours agoA biotech executive called the Supreme Court’s decision a “very important win” for the industry,...
FDA creates transparency principles for AI in medical devices
MedTech Dive via Yahoo Finance· 7 hours agoThe agency worked with regulators in the U.K. and Canada to determine how key information about...
Biotest wins FDA approval for plasma protein therapy
Pharmaceutical Technology via Yahoo Finance· 1 hour agoBiotest, a subsidiary of Grifols, announced that the US FDA granted approval for its plasma protein therapy Yimmugo earlier today (17 June). Yimmugo is...
Roberts court and judicial limitations
Olean Times Herald· 1 hour agoAmericans concerned about the U.S. Supreme Court's views on abortion may have been confused on Thursday when the court issued a unanimous ruling that...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- The Food and Drug Administration delayed a breast- and lung-cancer trial of an...
FDA Took Months to React to Complaint About Abbott's Formula Factory, Audit Finds
MedPage Today· 4 days agoThe FDA took more than 15 months to act on a whistleblower complaint it received about conditions at...
FDA again delays Drug Supply Chain Security Act enforcement
Becker’s Hospital Review· 10 hours agoPharmacies with 25 or fewer full-time employees now have until late 2026 to fulfill requirements of the Drug Supply Chain Security Act, according to the FDA. The agency announced ...
